Gene · 10128
Papers1,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N6-Methyladenosine (m6A) Reader LRPPRC-Mediated CXCL11 Induces Cell Inflammation to Drive Breast Cancer Cell Malignancy. | Crit Rev Immunol | 2025 | 39612279 | PubTator, text mining | PubMed |
| Comprehensive Analysis of RNA Methylation-Regulated Gene Signature and Immune Infiltration in Ischemia/Reperfusion-Induced Acute Kidney Injury. | Kidney Blood Press Res | 2025 | 39600181 | PubTator, text mining | PubMed |
| LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma. | Cancer Sci | 2025 | 39576738 | PubTator, text mining | PubMed |
| SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating LRPPRC. | Free Radic Biol Med | 2025 | 39557134 | PubTator, text mining | PubMed |
| The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. | Neuro Oncol | 2025 | 39215663 | PubTator, text mining | PubMed |
| NDUFA11 may be the disulfidptosis-related biomarker of ischemic stroke based on integrated bioinformatics, clinical samples, and experimental analyses. | Front Neurosci | 2024 | 39877656 | PubTator, text mining | PubMed |
| Identification of diagnostic biomarkers and molecular subtype analysis associated with m6A in Tuberculosis immunopathology using machine learning. | Sci Rep | 2024 | 39622968 | PubTator, text mining | PubMed |
| The mitochondrial mRNA-stabilizing protein SLIRP regulates skeletal muscle mitochondrial structure and respiration by exercise-recoverable mechanisms. | Nat Commun | 2024 | 39537626 | PubTator, text mining | PubMed |
| Comprehensive review on leucine-rich pentatricopeptide repeat-containing protein (LRPPRC, PPR protein): A burgeoning target for cancer therapy. | Int J Biol Macromol | 2024 | 39476900 | PubTator, text mining | PubMed |
| Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma. | Front Immunol | 2024 | 39445012 | PubTator, text mining | PubMed |
| Classification and functional analysis of disulfidptosis-associated genes in sepsis. | J Cell Mol Med | 2024 | 39400961 | PubTator, text mining | PubMed |
| Retraction: Mitochondrial-associated protein LRPPRC is related with poor prognosis potentially and exerts as an oncogene via maintaining mitochondrial function in pancreatic cancer. | Front Genet | 2024 | 39371420 | PubTator, text mining | PubMed |
| Unveiling disulfidptosis-related genes in HBV-associated hepatocellular carcinoma: an integrated study incorporating transcriptome and Mendelian randomization analyses. | J Cancer | 2024 | 39308675 | PubTator, text mining | PubMed |
| Publisher Correction: Structural basis of LRPPRC-SLIRP-dependent translation by the mitoribosome. | Nat Struct Mol Biol | 2024 | 39300173 | PubTator, text mining | PubMed |
| Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer. | J Gastrointest Oncol | 2024 | 39279954 | PubTator, text mining | PubMed |
| hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107/LATS2 signaling. | Biol Direct | 2024 | 39164777 | PubTator, text mining | PubMed |
| Structural basis of LRPPRC-SLIRP-dependent translation by the mitoribosome. | Nat Struct Mol Biol | 2024 | 39134711 | PubTator, text mining | PubMed |
| Genetic insights into the complexity of premature ovarian insufficiency. | Reprod Biol Endocrinol | 2024 | 39095891 | PubTator, text mining | PubMed |
| LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation. | Nucleic Acids Res | 2024 | 39087558 | PubTator, text mining | PubMed |
| A cross-tissue transcriptome-wide association study identifies new susceptibility genes for frailty. | Front Genet | 2024 | 39071775 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10128/papers?page=5